经导管支气管动脉栓塞术治疗肺部基础病变合并新型冠状病毒肺炎诱发咯血  

Transcatheter bronchial artery embolization for treating hemoptysis induced by underlying pulmonary disease complicated with COVID-19

作　　者：陈峰[1] 刘海英[2] 慈敏俊 万克娜 CHEN Feng;LIU Haiying;CI Minjun;WAN Kena(Department of Interventional Radiology Surgery,Hainan General Hospital,Haikou 570311,China;Department of Breast Surgery,Hainan General Hospital,Haikou 570311,China)

机构地区：[1]海南省人民医院综合介入科,海南海口570311 [2]海南省人民医院乳腺外科,海南海口570311

出　　处：《中国介入影像与治疗学》2023年第10期587-590,共4页Chinese Journal of Interventional Imaging and Therapy

摘　　要：目的观察经导管支气管动脉栓塞术(BAE)治疗肺部基础病变合并新型冠状病毒肺炎(COVID-19)诱发咯血的价值。方法纳入18例接受经导管BAE的肺部基础病变合并COVID-19咯血患者,观察其临床特征,根据临床转归分为治愈、显效、有效、无效及复发,评估BAE疗效。结果首次BAE后治愈6例(6/18,33.33%)、显效3例(3/18,16.67%)、有效3例(3/18,16.67%),无效1例(1/18,5.56%)、复发5例(5/18,27.78%);5例复发者经二次BAE后均治愈。未见脊髓损伤及异位栓塞等严重并发症。结论BAE治疗肺部基础病变合并COVID-19诱发咯血疗效确切,但短期内复发率较高。Objective To observe the value of transcatheter bronchial artery embolization(BAE)for treating hemoptysis induced by underlying pulmonary disease complicated with COVID-19.Methods Eighteen hemoptysis patients with underlying pulmonary disease and COVID-19 were enrolled.The clinical characteristics were observed.The therapeutic effects were divided into cured,significant effective,effective,ineffective or recurrent,and the value of BAE was evaluated.Results After the first time BAE,6 cases(6/18,33.33%)were cured,3 cases(3/18,16.67%)were significant effective,3 cases(3/18,16.67%)were effective,1 case(1/18,5.56%)was ineffective,while recurrence of hemoptysis occurred in 5 cases(5/18,27.78%).After the second time BAE,recurrent hemoptysis was cured in all 5 cases.No serious complication such as spinal cord injury nor ectopic embolism happened.Conclusion BAE was effective for treating hemoptysis induced by underlying pulmonary disease complicated with COVID-19,but with high short-term recurrent rate.

关 键 词：咯血 栓塞 治疗性 新型冠状病毒肺炎 

分 类 号：R563.1[医药卫生—呼吸系统] R815[医药卫生—内科学]